CAS 175414-77-4

(+)-7-[3(S)-Methoxy-4(S)-(methylamino)pyrrolidin-1-yl]-4-oxo-1-(2-thiazolyl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid

Description:

The chemical substance known as (+)-7-[3(S)-Methoxy-4(S)-(methylamino)pyrrolidin-1-yl]-4-oxo-1-(2-thiazolyl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid, with the CAS number 175414-77-4, is a complex organic compound characterized by its multi-cyclic structure, which includes a naphthyridine core and various functional groups. This compound features a thiazole ring and a pyrrolidine moiety, contributing to its potential biological activity. The presence of a methoxy group and a methylamino group suggests that it may exhibit specific interactions with biological targets, possibly influencing its pharmacological properties. The stereochemistry indicated by the (S) designations suggests that the compound has specific spatial arrangements that could affect its reactivity and interactions. Such compounds are often investigated for their potential therapeutic applications, particularly in fields like medicinal chemistry, where their ability to interact with biological systems is of significant interest. Overall, this substance exemplifies the complexity and diversity of organic molecules used in drug development.

Formula: C₁₈H₁₉N₅O₄S

InChI: InChI=1S/C18H19N5O4S/c1-19-12-8-22(9-13(12)27-2)14-4-3-10-15(24)11(17(25)26)7-23(16(10)21-14)18-20-5-6-28-18/h3-7,12-13,19H,8-9H2,1-2H3,(H,25,26)/t12-,13-/m0/s1

InChI key: InChIKey=XZAFZXJXZHRNAQ-STQMWFEESA-N

SMILES: O=C1C=2C(N(C=C1C(O)=O)C3=NC=CS3)=NC(=CC2)N4C[C@H](NC)[C@@H](OC)C4

Synonyms:

• 1,4-Dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
• 1,8-Naphthyridine-3-carboxylic acid, 1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-
• 1,8-Naphthyridine-3-carboxylic acid, 1,4-dihydro-7-[3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-, (3S-trans)-
• Ag-7352
• Sns-595
• Spc-595
• Voreloxin
• Vosaroxin

1,8-Naphthyridine-3-carboxylic acid, 1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-

CAS: 175414-77-4

Formula: C₁₈H₁₉N₅O₄S

Color and Shape: Solid

Molecular weight: 401.4396

Ref: IN-DA0020Z6

Voreloxin

CAS: 175414-77-4

Voreloxin (SNS-595) is a potent Topoisomerase II inhibitor with broad-spectrum anti-tumor activity. Phase 2.

Formula: C₁₈H₁₉N₅O₄S

Purity: 98%

Color and Shape: Solid

Molecular weight: 401.44

Ref: TM-T6724

Voreloxin

CAS: 175414-77-4

Voreloxin is a topoisomerase inhibitor that binds to the enzyme's active site, preventing it from breaking and rejoining DNA. Voreloxin has been shown to be minimally toxic in pre-clinical models of acute myeloid leukemia. It inhibits the activity of deoxyribonucleic acid (DNA) methyltransferases, which are enzymes that control DNA methylation and gene expression. Voreloxin is also an effective inhibitor against dna methyltransferase inhibitors, which are drugs used in chemotherapy for cancer treatment. Side-effects of voreloxin are minimal and include myeloid leukemia in animal models. Voreloxin has not been tested against other types of cancers.

Formula: C₁₈H₁₉N₅O₄S

Purity: Min. 95%

Molecular weight: 401.44 g/mol

Ref: 3D-AHA41477